Beyond the Individual: Group Dynamics in Psychedelic-Assisted Therapy

As interest in group psychedelic-assisted therapy grows, researchers are exploring diverse protocols, populations, and psychedelic medicines to enhance therapeutic outcomes and accessibility. This panel brings together experts conducting groundbreaking studies on group-based psychedelic therapy, offering insights into how different approaches can foster healing, connection, and transformation. Panelists will discuss MDMA-assisted group therapy for veterans struggling with PTSD, psilocybin-assisted therapy for metastatic cancer patients facing existential distress, and ketamine-assisted group therapy for individuals healing from identity-based trauma. By comparing methodologies, key learnings, and emerging outcomes, this discussion will highlight the unique benefits and challenges of the group therapy model and its potential to expand access and deepen therapeutic impact. Attendees will gain a deeper understanding of group psychedelic therapy’s evolving landscape, including best practices for facilitation, ethical considerations, and implications for future research and clinical applications.